Nicotine Polacrilex Patent Expiration
Nicotine Polacrilex was first introduced by Haleon Us Holdings Llc
Nicotine Polacrilex Patents
Given below is the list of patents protecting Nicotine Polacrilex, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Nicorette | US8323683 | Flavoring of drug-containing chewing gums | Apr 30, 2028 | Haleon Us Holdings |
Nicorette | US8501164 | Nicotine lozenge compositions | Jun 14, 2029 | Haleon Us Holdings |
Nicorette | US8940772 | Nicotine lozenge composition | Apr 30, 2029 | Haleon Us Holdings |
Explore Our Curated Drug Screens
Nicotine Polacrilex Generics
Several generic applications have been filed for Nicotine Polacrilex. The first generic version for Nicotine Polacrilex was by P And L Development Llc and was approved on Mar 15, 1999. And the latest generic version is by Fertin Pharma As and was approved on Dec 21, 2022.
Given below is the list of companies who have filed for Nicotine Polacrilex generic.
1. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Aug 3, 2021 |
EQ 4MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Aug 3, 2021 |
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | troche/lozenge | Over the counter | ORAL | N/A | May 13, 2022 |
EQ 4MG BASE | troche/lozenge | Over the counter | ORAL | N/A | May 13, 2022 |
3. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Aug 4, 2020 |
EQ 4MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Aug 4, 2020 |
4. FERTIN PHARMA
Fertin Pharma As has filed for 1 generic for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Fertin Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Dec 21, 2022 |
5. GLAXOSMITHKLINE CONS
Glaxosmithkline Consumer Healthcare has filed for 2 different strengths of generic version for Nicotine Polacrilex. All of these versions come by the name THRIVE. Given below are the details of the strengths of this generic introduced by Glaxosmithkline Cons.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Jun 19, 2007 |
EQ 4MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Jun 19, 2007 |
6. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Feb 18, 2009 |
EQ 4MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Feb 18, 2009 |
7. L PERRIGO CO
L Perrigo Co has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by L Perrigo Co.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | gum, chewing | Over the counter | BUCCAL | N/A | Sep 16, 2004 |
EQ 2MG BASE | gum, chewing | Over the counter | BUCCAL | N/A | Sep 16, 2004 |
8. P AND L
P And L Development Llc has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by P And L.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | troche/lozenge | Over the counter | ORAL | N/A | May 14, 2020 |
EQ 4MG BASE | troche/lozenge | Over the counter | ORAL | N/A | May 14, 2020 |
9. PERRIGO R AND D
Perrigo R And D Co has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | gum, chewing | Over the counter | BUCCAL | N/A | Dec 15, 2016 |
EQ 2MG BASE | gum, chewing | Over the counter | BUCCAL | N/A | Dec 15, 2016 |
10. PLD ACQUISITIONS
Pld Acquisitions Llc Dba Avema Pharma Solutions has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Pld Acquisitions.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Feb 7, 2019 |
EQ 2MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Feb 7, 2019 |
11. PPI-DAC
Perrigo Pharma International Dac has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Ppi-dac.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Oct 9, 2012 |
EQ 4MG BASE | troche/lozenge | Over the counter | ORAL | N/A | Oct 9, 2012 |
12. WATSON LABS
Watson Laboratories Inc has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Watson Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Jul 29, 2004 |
EQ 2MG BASE | gum, chewing | Discontinued | BUCCAL | N/A | Jul 29, 2004 |